Document is current
Any future updates will be listed below
-
Authors
Foersch, Sebastian https://orcid.org/0000-0002-4740-6900
Glasner, Christina
Woerl, Ann-Christin
Eckstein, Markus
Wagner, Daniel-Christoph
Schulz, Stefan
Kellers, Franziska https://orcid.org/0000-0003-1770-3610
Fernandez, Aurélie
Tserea, Konstantina
Kloth, Michael
Hartmann, Arndt
Heintz, Achim
Weichert, Wilko
Roth, Wilfried
Geppert, Carol
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
Jesinghaus, Moritz https://orcid.org/0000-0002-0018-5661
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (16SV8167)
Stage-I-Program of the University Medical Center Mainz Mainz Research School of Translational Biomedicine (TransMed) Manfred-Stolte-Foundation
Bundesministerium für Gesundheit (ZMVI1-2520DAT111)
Deutsche Krebshilfe (#70113864)
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 17 November 2022
First Online: 9 January 2023
Competing interests
: J.N.K. reports consulting services for Owkin (France), Panakeia (UK), and DoMore Diagnostics (Norway) and has received honoraria for lectures by MSD, Eisai, and Fresenius. The other authors declare no competing interests.
